Virta Health

Virta partners with forward-thinking employers and health plans to redefine metabolic care. Our industry-leading, sustainable results help your teams achieve better health outcomes while reducing long-term costs.

GLP-1 access is expanding, and so is demand. Virta helps Medicare plans balance access with affordability through responsible prescribing and nutrition-first care that drives long-term results without runaway drug costs.

Significant news from the White House last week: Millions of Medicare members will soon gain access to GLP-1s for obesity through new pricing deals. The announcement also teased the availability of lower-priced oral formulas, a change that would ripple through plans of all types. This is a win for members looking to access and afford these medications, but a major financial headwind for plan sponsors when demand surges. What now? Plan sponsors must act quickly to implement strategies that deliver both positive financial returns and lasting outcomes from added spend. This starts by pairing every GLP-1 prescription with an evidence-based nutrition and behavior change program. If you’re looking for a trusted partner in GLP-1 prescribing and deprescribing: Virta has been doing this for 10+ years. We’ve helped members sustain 85% weight loss a year after stopping the medication, and we’ve lowered costs for payers by cutting GLP-1 use for weight loss over 50% among current users. GLP-1s are a tool in the toolkit, but optimizing the spend requires a program like Virta. 👉 Join our experts as they unpack this news and what it means for plans on Wednesday, November 19: https://bit.ly/4p2BkWt

Virta partners with forward-thinking employers and health plans to redefine metabolic care. Our industry-leading, sustainable results help your teams achieve better health outcomes while reducing long-term costs.

Transform your organization’s approach to diabetes and weight loss. Virta partners with forward-thinking employers and health plans to set a new standard for metabolic care.